Skip to main content

Table 6 Association between selected gene polymorphisms and CHD

From: “Association of MTHFR and MS/MTR gene polymorphisms with congenital heart defects in North Indian population (Jammu and Kashmir): a case–control study encompassing meta-analysis and trial sequential analysis”

MODEL

OR (95% CI)

p-value

MTHFR C677T polymorphism

 Co-dominant

  CT vs CC

0.91 [0.27–3.12]

0.879

  TT vs CC

4.09 [0.36–46.35]

0.22

 Dominant

  CT + TT vs CC

1.23 [0.42–3.59]

0.71

 Recessive

  TT vs CT + CC

4.12[0.36–46.63]

0.234

 Allelic

  T vs C

1.49 [0.58–3.84]

0.40

MTHFR G1793A polymorphism

 Co-dominant

  GA vs GG

5.90 [2.46–14.11]

0.00002b

  AA vs GG

Not possiblea

-

 Dominant

  GA + AA vs GG

6.52 [2.75–15.43]

 < 0.0001b

 Recessive

  AA vs GA + GG

Not possiblea

-

 Allelic

  A vs G

5.68 [2.58–12.48]

 < 0.0001b

MS A2756G polymorphism

 Co-dominant

  AG vs AA

1.68 [0.81–3.52]

0.163

  GG vs AA

4.87 [0.43–55.71]

0.20

 Dominant

  AG + GG vs AA

1.80 [0.88–3.69]

0.11

 Recessive

  GG vs AG + AA

4.12[0.36–46.63]

0.2

 Allelic

  G vs A

1.73 [0.93–3.22]

0.08

  1. aSome genotype combinations were not observed, so it was not possible to calculate odds ratio
  2. bSignificant values